Note 13 PROVISION FOR INCOME TAXES:
The Company's operations in Greece have no tax free income threshold and are subject to taxation at a rate of 29% applied to all net income earned after $1 Euro. Further, after its first year of profitable operations, the Company is required to remit estimated income taxes prorated monthly based on the prior year's calculatd income taxes payable.
The Company's operations in the United Kingdom are subject to Corporation Tax at a single taxation rate of 20% calculated on net income. The Company's operations are subject to certain releif from taxation with respect to R&D credit claims and may be subject to "Patent Box" relief which provides for a lower rate of income tax payable on all licensing income generated from the corporate owned patents. There are numerous critera required to be met to qualify for such relief.
The Company has experienced losses since inception. As a result, it has incurred no Federal income tax. The Internal Revenue Code allows net operating losses (NOL's) to be carried forward and applied against future profits for a period of twenty years. The Greece Tax Code permits such carryforwards for a period of five years. The United Kingdom Tax Code permits such carryforwards indefinitely. The total of these NOL's at December 31, 2016 was $4,619,000 in the U.S., $1,244,000 in Greece and $306,000 in the U.K and at December 31, 2015 was $3,843,000 in the U.S., $800,840 in Greece and $453,700 in the U.K.
The provision for income taxes in US consists of the following:
|
|
| Year ended December 31, |
| |||||
|
|
| 2016 |
|
| 2015 |
| ||
| Current operations |
| $ | 348,400 |
|
| $ | 534,200 |
|
| Timing differences, Stock based compensation |
|
| (84,575 | ) |
|
| - |
|
| Less, Change in valuation allowance |
|
| (263,825 | ) |
|
| (534,200 | ) |
| Net refundable amount |
| $ | - |
|
| $ | - |
|
The provision for income taxes in Greece consists of the following:
|
|
| Year ended December 31, |
| |||||
|
|
| 2016 |
|
| 2015 |
| ||
| Current operations |
| $ | 128,670 |
|
| $ | 92,000 |
|
| Less, Change in valuation allowance |
|
| (128,670 | ) |
|
| (92,000 | ) |
| Net refundable amount |
| $ | - |
|
| $ | - |
|
The provision for income taxes in UK consists of the following:
|
|
| Year ended December 31, |
| |||||
|
|
|
| 2016 |
|
|
| 2015 |
|
| Current operations |
| $ | 27,780 |
|
| $ | 1,012,000 |
|
| Research and development |
|
| (57,180 | ) |
|
| (980,600 | ) |
| Less, Change in valuation allowance |
|
| 29,400 |
|
|
| (31,400 | ) |
| Net refundable amount |
| $ | - |
|
| $ | - |
|
The cumulative tax effect at the expected rates in U.S., in Greece and in U.K. for significant items comprising our net deferred tax amounts as of December 31, 2016 and 2015 are as follows:
|
|
| December 31, 2016 |
|
| December 31, 2015 |
| ||||||||||||||||||
|
|
| US Expected rate 34% |
|
| Greece Expected rate 29% |
|
| UK Expected rate 20% |
|
| US Expected rate 34% |
|
| Greece Expected rate 26% |
|
| UK Expected rate 20% |
| ||||||
| Deferred tax asset attributable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
| Net operating loss carryover |
| $ | 4,619,000 |
|
| $ | 1,244,000 |
|
| $ | 306,000 |
|
| $ | 2,403,548 |
|
| $ | 231,800 |
|
| $ | 226,800 |
|
| Less, Valuation allowance |
|
| (4,619,000 | ) |
|
| (1,244,000 | ) |
|
| (306,000 | ) |
|
| (2,403,548 | ) |
|
| (231,800 | ) |
|
| (226,800 | ) |
| Net deferred tax asset |
| $ | - |
|
| $ |
|
|
| $ | - |
|
| $ | - |
|
| $ | - |
|
| $ | - |
|
The Company has no tax position at December 31, 2016 and 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the period presented. The Company had no accruals for interest and penalties at December 31, 2016 and 2015. The Companys utilization of any net operating loss carry forward may be unlikely as a result of its intended activities.
The Company recognized deferred tax assets and liabilities for both the expected impact of differences between the financial statements and the tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit carryforwards. The Company will establish a valuation allowance to reflect the likelihood of realization of deferred tax assets.